Eligibility to COAPT Trial in the Daily Practice: A Real-World Experience

被引:0
|
作者
Zancanaro, Edoardo [1 ]
机构
[1] Osped San Raffaele, Milan, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
TCT-336
引用
收藏
页码:B135 / B136
页数:2
相关论文
共 50 条
  • [41] A Real-World Experience to Engage Students in Evidence-Based Practice
    Ruskjer, Bev
    JOURNAL OF NURSING EDUCATION, 2010, 49 (11) : 660 - 660
  • [42] IMPROVING PROGNOSIS OF HCC IN THE REAL-WORLD CLINICAL PRACTICE: AN ITALIAN EXPERIENCE
    Borzio, M.
    Sacco, R.
    Fanigliulo, L.
    Parisi, G.
    Francica, G.
    Dionigi, E.
    Salvagnini, M.
    Di Fonzo, M.
    Salmi, A.
    De Sio, I.
    Vicari, S.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S108 - S108
  • [43] EXPERIENCE IN IMPLEMENTING CLINICAL TRIAL TO REAL-WORLD DATA (RWD) LINKAGE
    NajafZadeh, M.
    Saunders, D.
    Demirci, S.
    Niamathullah, S.
    Vaccaro, T.
    McConnochie, B.
    Polewaczyk, J.
    Tyagi, A.
    Ahmed, A.
    Oromendia, A.
    VALUE IN HEALTH, 2024, 27 (06) : S393 - S393
  • [44] Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure Population
    Hakansson, Erik
    Norberg, Helena
    Sjalander, Sara
    Lindmark, Krister
    CARDIOVASCULAR THERAPEUTICS, 2021, 2021
  • [45] Eligibility for Dapagliflozin and Empagliflozin in a Real-world Heart Failure Population
    Thorvaldsen, Tonje
    Ferrannini, Giulia
    Mellbin, Linda
    Benson, Lina
    Cosentino, Francesco
    Mcmurray, John J., V
    Dahlstrom, Ulf
    Lund, Lars H.
    Savarese, Gianluigi
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (07) : 1050 - 1062
  • [46] Eligibility for acetazolamide in real-world acute heart failure patients
    Gerardo, A.
    Fialho, I.
    Passos, M.
    Miranda, I.
    Mateus, C.
    Beringuilho, M.
    Lopes, J.
    Faria, D.
    Roque, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 164 - 164
  • [47] Eligibility for vericiguat in a real-world, contemporary heart failure population
    Vergaro, Giuseppe
    Aimo, Alberto
    Gentile, Francesco
    Mandoli, Giulia Elena
    Focardi, Marta
    Castiglione, Vincenzo
    Giannoni, Alberto
    Panichella, Giorgia
    Fornaro, Alessandra
    Carluccio, Erberto
    Liga, Riccardo
    Salatin, Mattia
    Passino, Claudio
    Piepoli, Massimo F.
    Cameli, Matteo
    Cappelli, Francesco
    Di Mario, Carlo
    Emdin, Michele
    ESC HEART FAILURE, 2024, 11 (06): : 3523 - 3529
  • [48] Impact of Trial Eligibility Criteria on Outcomes of 1183 Patients With Follicular Lymphoma Treated in the Real-World Setting
    Bennedsen, Tine Litske
    Simonsen, Mikkel Runason
    Jensen, Paw
    Brown, Peter
    Josefsson, Paer
    Khurana, Arushi
    Maurer, Matthew
    Clausen, Michael Roost
    Dessau-Arp, Andriette
    Jorgensen, Jennifer Bogh
    Jorgensen, Judit
    Larsen, Thomas Stauffer
    Pedersen, Lars Moller
    Jakobsen, Lasse Hjort
    El-Galaly, Tarec Christoffer
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025,
  • [49] Clinical trial eligibility of a real-world connective tissue disease cohort: Results from the LEAP cohort
    Dyball, Sarah
    Madenidou, Anastasia-Vasiliki
    Rodziewicz, Mia
    Reynolds, John A.
    Herrick, Ariane L.
    Haque, Sahena
    Chinoy, Hector
    Bruce, Ellen
    Parker, Ben
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 67
  • [50] Real-world Experience With Once-daily Gabapentin for the Treatment of Postherpetic Neuralgia (PHN)
    Markley, Herbert G.
    Dunteman, Edwin D.
    Kareht, Stephanie
    Sweeney, Michael
    CLINICAL JOURNAL OF PAIN, 2015, 31 (01): : 58 - 65